What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His primary areas of investigation include Internal medicine, Gastroenterology, Placebo, Surgery and Crohn's disease.
His Internal medicine study which covers Immunology that intersects with Microbiology.
His Gastroenterology study incorporates themes from Larazotide, Chemotherapy, Certolizumab pegol, Gluten free and Corticosteroid.
The various areas that he examines in his Placebo study include Crohn's Disease Activity Index, Etrolizumab, Gastrointestinal agent and Infliximab.
His work deals with themes such as Vedolizumab, Adalimumab and Pharmacokinetics, which intersect with Surgery.
His Crohn's disease research is multidisciplinary, relying on both Methotrexate, Anemia, Randomization and Prednisone.
His most cited work include:
- Infliximab Maintenance Therapy for Fistulizing Crohn's Disease (1693 citations)
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease (1487 citations)
- Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial (1331 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Inflammatory bowel disease, Crohn's disease and Ulcerative colitis.
His Internal medicine study incorporates themes from Placebo, Endocrinology and Surgery.
His Surgery study focuses on Randomized controlled trial in particular.
His Gastroenterology research is multidisciplinary, incorporating elements of Feces, Urine, Adverse effect and Certolizumab pegol.
His work in Inflammatory bowel disease covers topics such as Immunology which are related to areas like Microbiology.
His Infliximab research incorporates themes from Gastrointestinal agent, Adalimumab, Maintenance therapy and Retrospective cohort study.
He most often published in these fields:
- Internal medicine (60.94%)
- Gastroenterology (40.19%)
- Inflammatory bowel disease (26.98%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (60.94%)
- Gastroenterology (40.19%)
- Ulcerative colitis (18.68%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Gastroenterology, Ulcerative colitis, Crohn's disease and Inflammatory bowel disease.
He has researched Internal medicine in several fields, including Surgery and Oncology.
His study ties his expertise on Immunology together with the subject of Gastroenterology.
His work investigates the relationship between Ulcerative colitis and topics such as Randomized controlled trial that intersect with problems in Observational study, Physical therapy and Placebo.
His Crohn's disease research incorporates elements of Cross-sectional study, Mediterranean diet and Moderate to severe.
His work deals with themes such as Breastfeeding and Intensive care medicine, which intersect with Inflammatory bowel disease.
Between 2015 and 2021, his most popular works were:
- Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection (139 citations)
- Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD (137 citations)
- An overview of clinical decision support systems: benefits, risks, and strategies for success. (101 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Richard N. Fedorak mainly investigates Internal medicine, Crohn's disease, Infliximab, Ulcerative colitis and Gastroenterology.
The study incorporates disciplines such as Clostridium difficile and Immunology in addition to Internal medicine.
His Crohn's disease research includes elements of Inflammatory bowel disease and Abdominal surgery.
His studies deal with areas such as Gastrointestinal agent and Adalimumab as well as Infliximab.
The various areas that Richard N. Fedorak examines in his Ulcerative colitis study include Tolerability, Immune system and Intensive care medicine.
The concepts of his Gastroenterology study are interwoven with issues in Immunohistochemistry, Intestinal mucosa, Staining, Stain and Biopsy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
